Sign Up to like & get
recommendations!
0
Published in 2020 at "Immunotherapy"
DOI: 10.2217/imt-2019-0120
Abstract: Aim: We aimed to systematically characterize ear and labyrinth toxicities after immune checkpoint inhibitors (ICIs) initiation. Materials & methods: Data were extracted from the US FDA Adverse Event Reporting System database. Disproportionality analysis including information…
read more here.
Keywords:
labyrinth toxicities;
immune checkpoint;
checkpoint inhibitors;
disproportionality analysis ... See more keywords